Clinical Phenotypes in Relation to Outcomes in Heart Failure Patients With Cardiac Resynchronization Therapy and Defibrillators (CRT-D): An Unsupervised Cluster Analysis

心脏再同步治疗和除颤器(CRT-D)治疗心力衰竭患者的临床表型与预后的关系:一项无监督聚类分析

阅读:1

Abstract

BACKGROUND: Patients with heart failure undergoing cardiac resynchronization therapy (CRT) are a heterogenous and complex population. OBJECTIVE: To identify different clusters of patients with CRT-D and to evaluate the associations with clinical outcomes, using cluster analysis (CAs). METHODS: Three agglomerative hierarchical CAs were performed in CRT-D patients seen between 2010 and 2019 in French hospitals. Associations between clusters and death at 1 year and death during the whole follow-up (FU) were evaluated. RESULTS: The study included 23 029 CRT-D patients, who were analyzed in three ways, as follows: the first group was a 50% random sample of all patients (n = 11 514), the second group included patients who were dead at 1 year (n = 1604) and the third group included those alive at 3 years FU (n = 14 228). A CA was performed on each group of patients. Four clusters were identified: Cluster 1 corresponded to the low-risk phenotype; Cluster 2 to patients with coronary artery disease (CAD) with few cardiovascular (CV) risk factors and comorbidities; Cluster 3 included patients with CV risk factors and comorbidities, but low CAD; Cluster 4 corresponded to clinically complex phenotype (CAD with CV risk factors and comorbidities). Compared with Cluster 1, Clusters 2, 3, and 4 were independently associated with an increased risk of all-cause death at 1-year FU and during the whole FU (Cluster 2: hazard ratio (HR) 1.21, 95% confidence interval (CI) 1.08-1.36; Cluster 3: HR 1.15, 95% CI 1.04-1.26; and Cluster 4: HR 1.79, 95% CI 1.65-1.96). CONCLUSION: CAs identified four statistically driven groups of CRT recipients, with specific clinical phenotypes and associated with different risks for all-cause death.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。